France / Français
HKBU and CUHK jointly develop Spermine Risk Score for diagnosis of prostate cancer
One year ago - By News Medical
Researchers from Hong Kong Baptist University and the Faculty of Medicine at The Chinese University of Hong Kong have jointly developed the Spermine Risk Score which, coupled with the use of a urine test, provides a non-invasive and more reliable method for the diagnosis of prostate cancer.
Read more ...
The headlines of Master Doctor
Can Influenza Vaccination Protect Against Alzheimer's Disease?
Individuals who received influenza vaccine were 40% less likely than their non-vaccinated counterparts to develop Alzheimer's disease.
VIDEO: Study queries association between HSD3B1 genotype and prostate cancer...
In this video, Nima Sharifi, MD, director, Center for GU Malignancies Research, Lerner Research Institute, Cleveland Clinic, discusses a new study regarding metastatic prostate...